Halozyme Therapeutics, Inc. (HALO) said Thursday that it has appointed David Ramsay as Chief Financial Officer.
Ramsay was most recently Vice President, Corporate Development at Halozyme.
Ramsay has had a distinguished tenure at Halozyme, joining in 2003 as Chief Financial Officer before serving as Vice President, Corporate Development. His numerous achievements and accomplishments at Halozyme include spearheading the process of taking Halozyme public in 2004. Prior to Halozyme, he served in various financial roles including Vice President, Chief Financial Officer of Lathian Systems. Before Lathian, Ramsay was Vice President, Treasurer of ICN Pharmaceuticals, now called Valeant Pharmaceuticals International.
For comments and feedback: editorial@rttnews.com